Peptide Reference
Humanin
Humanin
A mitochondrial-derived peptide with potent cytoprotective effects. One of the first mitochondrial peptides discovered, showing promise for age-related diseases and metabolic conditions.
Status
research
Category
anti aging
Typical cost
$100-200/vial (10mg)
Mechanism
Binds to specific receptors on cell surfaces and within mitochondria. Inhibits apoptosis, reduces oxidative stress, and improves mitochondrial function. Activates pro-survival pathways and suppresses inflammatory responses.
Potential benefits
- Neuroprotection
- Improved insulin sensitivity
- Reduced oxidative stress
- Anti-apoptotic effects
- Metabolic enhancement
- Potential longevity benefits
Reported side effects
- Limited human data
- Injection site reactions
- Unknown long-term effects
Common dosing references
subcutaneous
0.5-2mg · Daily
4-8 weeks
Research notes
Humanin and Alzheimer's disease
2006
Demonstrated neuroprotective effects and improved cognitive markers in Alzheimer's models
Regulatory and sourcing notes
Research chemical only. Not FDA-approved. Under investigation for Alzheimer's and metabolic diseases.
Research peptide with limited availability. Part of the mitochondrial peptide family.
Find peptide-aware clinics
Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.